Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,228 | -63,534 | -29,154 | -80,546 | -54,963 |
| Depreciation Amortization | 1,676 | 1,079 | 509 | 1,319 | 860 |
| Accounts payable and accrued liabilities | -440 | 312 | -522 | 1,955 | 2,933 |
| Other Working Capital | -14,314 | -7,696 | -4,314 | -16,113 | -973 |
| Other Operating Activity | 14,530 | 8,398 | 4,749 | 9,602 | 5,857 |
| Operating Cash Flow | $-101,776 | $-61,441 | $-28,732 | $-83,783 | $-46,286 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,420 | -2,092 | -1,160 | -679 | -370 |
| Investing Cash Flow | $-2,420 | $-2,092 | $-1,160 | $-679 | $-370 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 60,000 | 60,000 |
| Common Stock Issued | 6,448 | 6,085 | 5,051 | 235,381 | 234,350 |
| Other Financing Activity | 107 | 107 | 107 | -2,909 | -2,289 |
| Financing Cash Flow | $6,555 | $6,192 | $5,158 | $292,472 | $292,061 |
| Beginning Cash Position | 337,790 | 337,790 | 337,790 | 129,780 | 129,780 |
| End Cash Position | 240,149 | 280,449 | 313,056 | 337,790 | 375,185 |
| Net Cash Flow | $-97,641 | $-57,341 | $-24,734 | $208,010 | $245,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,776 | -61,441 | -28,732 | -83,783 | -46,286 |
| Capital Expenditure | -2,420 | -2,092 | -1,160 | -679 | -370 |
| Free Cash Flow | -104,196 | -63,533 | -29,892 | -84,462 | -46,656 |